# US 2020/0391016 A1 · Method For Bypassing Defective Portions Of A Heart

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0391016 A1
- Document ID: US20200391016A1
- Status: Published application
- Kind: A1
- Application number: 16/904,432
- Filed: 2020-06-17
- Published: 2020-12-17
- Earliest claimed: 2019-06-17
- Assignees: NXT Biomedical, LLC
- Applicants: NXT Biomedical
- Inventors: Joseph Passman; Robert S. Schwartz; Robert C. Taft; Stanton J. Rowe; Alexander Siegel; Glen Rabito
- Web page: https://patentgrep.com/patent/US20200391016A1

## CPC

- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61M 27/002: {Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202)}
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61F 2/07: Stent-grafts
- A61F 2/2475: {Venous valves}
- A61F 2/88: the wire-like elements formed as helical or spiral coils
- A61F 2/95: Instruments specially adapted for placement or removal of stents or stent-grafts
- A61B 2018/00357: {Endocardium}
- A61B 2018/00577: {Ablation}
- A61B 2018/00601: {Cutting}
- A61F 2/06: Blood vessels
- A61F 2/2427: {Devices for manipulating or deploying heart valves during implantation}
- A61F 2210/0076: multilayered, e.g. laminated structures
- A61M 2205/0266: Shape memory materials
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods and techniques are disclosed for performing transcatheter procedures on a patient that result in similar blood flow changes to the surgical Blalock-Taussig procedure, the Glenn procedure, and the Fontan procedure. Since these transcatheter procedures do not necessarily involve open chest surgery, they tend to be less traumatic for the patient, quicker and easier to perform, and may result in better patient outcomes.

## Claims

### Claim 1

A method for treating a heart defect, comprising:
advancing a delivery catheter through a wall of a pulmonary artery and a wall of an aorta; and,
delivering a shunt scaffold within the wall of the pulmonary artery and the wall of the aorta to create a shunt between the pulmonary artery and the aorta.

### Claim 2 (depends on 1)

The method of claim 1, wherein advancing a delivery catheter is preceded by advancing a guidewire from the pulmonary artery into the aorta.

### Claim 3 (depends on 2)

The method of claim 2, wherein advancing the guidewire from the pulmonary artery into the aorta is preceded by advancing a target catheter into the aorta and deploying a snare at a location adjacent to the pulmonary artery; wherein the snare is configured to resist puncture by the guidewire.

### Claim 4 (depends on 3)

The method of claim 3, wherein the delivery catheter is advanced over the guidewire, into the pulmonary artery, and into the aorta.

### Claim 5 (depends on 4)

The method of claim 4, wherein the guidewire is positioned through a heart wall formed from an undeveloped tricuspid valve.

### Claim 6

A method for treating a heart defect, comprising:
advancing a delivery catheter through a wall of a superior vena cava and a wall of a right pulmonary artery; and,
delivering a shunt scaffold within the wall of the superior vena cava and the wall of the right pulmonary artery.

### Claim 7 (depends on 6)

The method of claim 6, wherein advancing the delivery catheter through the wall of the superior vena cava and the wall of the right pulmonary artery is proceeded by advancing a target catheter into the right pulmonary artery and deploying a snare from a distal end of the target catheter, adjacent to the superior vena cava.

### Claim 8 (depends on 7)

The method of claim 7, wherein advancing the target catheter into the right pulmonary artery is preceded by advancing a guidewire into the superior vena cava and into the right pulmonary artery; and advancing the delivery catheter over the guidewire and partially into the right pulmonary artery.

### Claim 9 (depends on 8)

The method of claim 8, further comprising delivering a stent containing a one-way valve in the superior vena cava between the shunt scaffold and a right atrium of a heart, wherein the one-way valve is configured to allow blood to only flow in a direction away from the right atrium.

### Claim 10 (depends on 8)

The method of claim 8, wherein advancing the guidewire into the superior vena cava is preceded by delivering a covered stent within an aorta to cover and close a shunt between the aorta and a pulmonary artery trunk.

### Claim 11

A method for treating a heart defect, comprising:
advancing a distal end of a delivery catheter into a superior vena cava; and,
delivering a covered stent between the superior vena cava, through the right atrium, and into the inferior vena cava.

### Claim 12 (depends on 11)

The method of claim 11, wherein the covered stent is deployed over a one-way stent valve located in the superior vena cava.

### Claim 13 (depends on 11)

The method of claim 11, wherein the covered stent is deployed prior to a shunt connecting the superior vena cava and a right pulmonary artery; wherein the shunt remains substantially uncovered by the covered stent.

### Claim 14

A method for treating a heart defect, comprising:
advancing a first delivery catheter through a wall of a pulmonary artery trunk and a wall of an aorta;
delivering a first shunt scaffold within the wall of the pulmonary artery trunk and the wall of the aorta to create a shunt between the pulmonary artery trunk and the aorta;
advancing a second delivery catheter into the pulmonary artery trunk and closing a passage through the first shunt scaffold;
advancing a third delivery catheter through a wall of a superior vena cava and a wall of a right pulmonary artery;
delivering a second shunt scaffold within the wall of the superior vena cava and the wall of the right pulmonary artery;
delivering a stent valve containing a one-way valve mechanism into the superior vena cava between the second shunt scaffold and a right atrium;
advancing a fourth delivery catheter into the superior vena cava;
delivering a covered stent within the superior vena cava, the right atrium, and the inferior vena cava, such that the second stent scaffold remains substantially uncovered and the stent valve remains substantially covered.

### Claim at position 15

15-22. (canceled)
